Postoperative Return to Sexual Activity

NCT05342090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2025-04-02

No results posted yet for this study

Summary

To determine if standardized counselling regarding first sexual encounter after pelvic reconstructive surgery for pelvic organ prolapse and / or urinary incontinence improves postoperative preparedness to return to sexual activity and sexual function.

Conditions

  • Sexual Function Disturbances
  • Pelvic Organ Prolapse
  • Stress Urinary Incontinence
  • Surgery

Interventions

OTHER

Structured Counselling Tool

Participants will be administered a Structured Counselling Tool that addresses the following themes: outside influences, conflicting emotions, uncertainty, sexual changes and stability, normalization, self-image

Sponsors & Collaborators

  • University of Wisconsin, Madison

    collaborator OTHER
  • Albany Medical College

    collaborator OTHER
  • Penn State University

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • University of Chicago

    collaborator OTHER
  • University of Florida

    collaborator OTHER
  • WellSpan Health

    collaborator OTHER
  • University of New Mexico

    collaborator OTHER
  • Weill Medical College of Cornell University

    collaborator OTHER
  • University of Texas at Austin

    collaborator OTHER
  • University of Calgary

    lead OTHER

Principal Investigators

  • Shunaha Kim-Fine, MD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-05
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05342090 on ClinicalTrials.gov